These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

548 related items for PubMed ID: 15528260

  • 21. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus.
    Sahin I, Alkan A, Keskin L, Cikim A, Karakas HM, Firat AK, Sigirci A.
    J Diabetes Complications; 2008; 22(4):254-60. PubMed ID: 18413166
    [Abstract] [Full Text] [Related]

  • 22. Monitoring interferon β treatment response with magnetic resonance spectroscopy in relapsing remitting multiple sclerosis.
    Yetkin MF, Mirza M, Dönmez H.
    Medicine (Baltimore); 2016 Sep; 95(36):e4782. PubMed ID: 27603381
    [Abstract] [Full Text] [Related]

  • 23. Serial contrast-enhanced magnetic resonance imaging and spectroscopic imaging of acute multiple sclerosis lesions under high-dose methylprednisolone therapy.
    Schocke MF, Berger T, Felber SR, Wolf C, Deisenhammer F, Kremser C, Seppi K, Aichner FT.
    Neuroimage; 2003 Oct; 20(2):1253-63. PubMed ID: 14568494
    [Abstract] [Full Text] [Related]

  • 24. Cerebral metabolite patterns in dialysis patients: evaluation with H-1 MR spectroscopy.
    Geissler A, Fründ R, Kohler S, Eichhorn HM, Krämer BK, Feuerbach S.
    Radiology; 1995 Mar; 194(3):693-7. PubMed ID: 7862964
    [Abstract] [Full Text] [Related]

  • 25. TI-relaxation time changes over five years in relapsing-remitting multiple sclerosis.
    Papadopoulos K, Tozer DJ, Fisniku L, Altmann DR, Davies G, Rashid W, Thompson AJ, Miller DH, Chard DT.
    Mult Scler; 2010 Apr; 16(4):427-33. PubMed ID: 20086026
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
    Elias AE, Carlos RC, Smith EA, Frechtling D, George B, Maly P, Sundgren PC.
    Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Gray matter N-acetyl aspartate deficits in secondary progressive but not relapsing-remitting multiple sclerosis.
    Adalsteinsson E, Langer-Gould A, Homer RJ, Rao A, Sullivan EV, Lima CA, Pfefferbaum A, Atlas SW.
    AJNR Am J Neuroradiol; 2003 Sep; 24(10):1941-5. PubMed ID: 14625214
    [Abstract] [Full Text] [Related]

  • 31. Localized (1)H magnetic resonance spectroscopy in mainly cortical gray matter of patients with multiple sclerosis.
    Sarchielli P, Presciutti O, Tarducci R, Gobbi G, Alberti A, Pelliccioli GP, Chiarini P, Gallai V.
    J Neurol; 2002 Jul; 249(7):902-10. PubMed ID: 12140676
    [Abstract] [Full Text] [Related]

  • 32. Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome.
    Stromillo ML, Giorgio A, Rossi F, Battaglini M, Hakiki B, Malentacchi G, Santangelo M, Gasperini C, Bartolozzi ML, Portaccio E, Amato MP, De Stefano N.
    Neurology; 2013 Jun 04; 80(23):2090-4. PubMed ID: 23635962
    [Abstract] [Full Text] [Related]

  • 33. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A, Kulle B, Gadmar ØB, Josefsen R, Kumar T, Nakstad PH.
    Eur J Radiol; 2011 Nov 04; 80(2):462-70. PubMed ID: 20708868
    [Abstract] [Full Text] [Related]

  • 34. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A, Josefsen R, Kulle B, Maehlen J, Schellhorn T, Gadmar Ø, Kumar T, Haakonsen M, Langberg CW, Nakstad PH.
    Acta Radiol; 2010 Apr 04; 51(3):316-25. PubMed ID: 20092374
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis.
    Tartaglia MC, Narayanan S, De Stefano N, Arnaoutelis R, Antel SB, Francis SJ, Santos AC, Lapierre Y, Arnold DL.
    J Neurol; 2002 Oct 04; 249(10):1382-90. PubMed ID: 12382153
    [Abstract] [Full Text] [Related]

  • 38. 1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS.
    Suhy J, Rooney WD, Goodkin DE, Capizzano AA, Soher BJ, Maudsley AA, Waubant E, Andersson PB, Weiner MW.
    Mult Scler; 2000 Jun 04; 6(3):148-55. PubMed ID: 10871825
    [Abstract] [Full Text] [Related]

  • 39. Statistics for investigation of multimodal MR imaging data and an application to multiple sclerosis patients.
    Fu L, Wolfson C, Worsley KJ, De Stefano N, Collins DL, Narayanan S, Arnold DL.
    NMR Biomed; 1996 Dec 04; 9(8):339-46. PubMed ID: 9176888
    [Abstract] [Full Text] [Related]

  • 40. Quantitative diffusion measurements in focal multiple sclerosis lesions: correlations with appearance on TI-weighted MR images.
    Nusbaum AO, Lu D, Tang CY, Atlas SW.
    AJR Am J Roentgenol; 2000 Sep 04; 175(3):821-5. PubMed ID: 10954474
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.